These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8584701)

  • 21. siRNA-mediated antitumorigenesis for drug target validation and therapeutics.
    Lu PY; Xie FY; Woodle MC
    Curr Opin Mol Ther; 2003 Jun; 5(3):225-34. PubMed ID: 12870431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Molecular therapy for human cancer with tumor suppressor p53 gene transfer].
    Fujiwara T; Inoue F; Tanaka N
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):194-200. PubMed ID: 9474928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo.
    Kircheis R; Schüller S; Brunner S; Ogris M; Heider KH; Zauner W; Wagner E
    J Gene Med; 1999; 1(2):111-20. PubMed ID: 10738575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approaches to enhance cancer radiotherapy employing gene transfer methods.
    Buchsbaum DJ; Raben D; Stackhouse MA; Khazaeli MB; Rogers BE; Rosenfeld ME; Liu T; Curiel DT
    Gene Ther; 1996 Dec; 3(12):1042-68. PubMed ID: 8986431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninfectious gene transfer and expression systems for cancer gene therapy.
    Cooper MJ
    Semin Oncol; 1996 Feb; 23(1):172-87. PubMed ID: 8607027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strategies to accomplish gene delivery via the receptor-mediated endocytosis pathway.
    Cristiano RJ; Curiel DT
    Cancer Gene Ther; 1996; 3(1):49-57. PubMed ID: 8785712
    [No Abstract]   [Full Text] [Related]  

  • 27. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protocol for gene transduction and expansion of human T lymphocytes for clinical immunogene therapy of cancer.
    Lamers CH; Willemsen RA; Luider BA; Debets R; Bolhuis RL
    Cancer Gene Ther; 2002 Jul; 9(7):613-23. PubMed ID: 12082462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor.
    Bonsted A; Engesaeter BØ; Høgset A; Maelandsmo GM; Prasmickaite L; D'Oliveira C; Hennink WE; van Steenis JH; Berg K
    J Gene Med; 2006 Mar; 8(3):286-97. PubMed ID: 16342300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant polymers for cancer gene therapy: a minireview.
    Haider M; Hatefi A; Ghandehari H
    J Control Release; 2005 Dec; 109(1-3):108-19. PubMed ID: 16263190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A chimeric fusion protein containing transforming growth factor-alpha mediates gene transfer via binding to the EGF receptor.
    Fominaya J; Uherek C; Wels W
    Gene Ther; 1998 Apr; 5(4):521-30. PubMed ID: 9614577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined targeting of adenoviruses to integrins and epidermal growth factor receptors increases gene transfer into primary glioma cells and spheroids.
    Grill J; Van Beusechem VW; Van Der Valk P; Dirven CM; Leonhart A; Pherai DS; Haisma HJ; Pinedo HM; Curiel DT; Gerritsen WR
    Clin Cancer Res; 2001 Mar; 7(3):641-50. PubMed ID: 11297260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer.
    Mendelsohn J; Baselga J
    J Clin Oncol; 2003 Jul; 21(14):2787-99. PubMed ID: 12860957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors.
    Yazawa H; Murakami T; Li HM; Back T; Kurosaka K; Suzuki Y; Shorts L; Akiyama Y; Maruyama K; Parsoneault E; Wiltrout RH; Watanabe M
    Cancer Gene Ther; 2006 Nov; 13(11):993-1001. PubMed ID: 16763608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment.
    Lemmon MJ; van Zijl P; Fox ME; Mauchline ML; Giaccia AJ; Minton NP; Brown JM
    Gene Ther; 1997 Aug; 4(8):791-6. PubMed ID: 9338007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of gene delivery to cancer cells by a retargeted adenovirus.
    Oh KS; Engler JA; Joung I
    J Microbiol; 2005 Apr; 43(2):179-82. PubMed ID: 15880094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeted gene-delivery strategies for angiostatic cancer treatment.
    Brandwijk RJ; Griffioen AW; Thijssen VL
    Trends Mol Med; 2007 May; 13(5):200-9. PubMed ID: 17379575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy progress and prospects: cancer gene therapy using tumour suppressor genes.
    McNeish IA; Bell SJ; Lemoine NR
    Gene Ther; 2004 Mar; 11(6):497-503. PubMed ID: 14762396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the epidermal growth factor receptor: a clinical reality.
    Baselga J
    J Clin Oncol; 2001 Sep; 19(18 Suppl):41S-44S. PubMed ID: 11560970
    [No Abstract]   [Full Text] [Related]  

  • 40. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
    Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
    Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.